Appendix 3Y
Change of Director's Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director's Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.
Introduced 30/09/01 Amended 01/01/11
Name of entity | Cellmid Limited |
ABN | 69 111 304 119 |
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
Name of Director | Ms Maria Halasz |
Date of last notice | 13 September 2018 |
Part 1 - Change of director's relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.
Direct or indirect interest | Indirect |
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. | Direct Capital Group Pty Ltd and Direct Capital Pty Ltd - Entities controlled by the Director |
Date of change | 13 November 2018, 12 November 2018 and 30 October 2018 |
No. of securities held prior to change | Direct 420,000 fully paid ordinary shares 400,000 fully paid ordinary (loan) shares Indirect 1,016,808 fully paid ordinary shares |
Class | Fully paid ordinary shares |
Number acquired | 522,130 |
Number disposed | Nil |
+ See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 1
Appendix 3Y
Change of Director's Interest Notice
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation | 22,130 at $0.35 per share (total value of $7,745.50) 500,000 at deemed issue price of $0.37 per share |
No. of securities held after change | Direct 420,000 fully paid ordinary shares 400,000 fully paid ordinary (loan) shares Indirect 1,538,938 fully paid ordinary shares |
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back | 22,130 through on market trades 500,000 issued in consideration of FY2018 performance, as approved at the Company's 2018 AGM held on 8 November 2018 |
Part 2 - Change of director's interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.
Detail of contract | N/A |
Nature of interest | N/A |
Name of registered holder (if issued securities) | N/A |
Date of change | N/A |
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed | N/A |
Interest acquired | N/A |
Interest disposed | N/A |
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation | N/A |
Interest after change | N/A |
Part 3 - +Closed period
+ See chapter 19 for defined terms.
Appendix 3Y Page 2
01/01/2011
Appendix 3Y
Change of Director's Interest Notice
Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required? | No |
If so, was prior written clearance provided to allow the trade to proceed during this period? | N/A |
If prior written clearance was provided, on what date was this provided? | N/A |
+ See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 3
Attachments
- Original document
- Permalink
Disclaimer
Cellmid Limited published this content on 13 November 2018 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 13 November 2018 03:33:02 UTC